Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

The Potential of Digital Twins for Pediatric Rare Diseases.

CPT: pharmacometrics & systems pharmacology·2026
Same author

Genetic interactions, synthetic lethality and complexity in cancer vulnerability mapping-Insights and perspectives from the 2nd EuroDepMap symposium.

FEBS letters·2026
Same author

Integrative multi-omics defines melanoma drug response networks and ARID1A-dependent resistance mechanisms.

Molecular systems biology·2026
Same author

RP3Net: a deep learning model for predicting recombinant protein production in Escherichia coli.

Bioinformatics (Oxford, England)·2026
Same author

Endoglin as a BMP9 co-receptor in vascular endothelial cells: prodomain displacement and TGFBRII recruitment.

Nature communications·2025
Same author

Basic Science and Pathogenesis.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same journal

Social Drivers of Health in the Electronic Health Record.

Annual review of biomedical data science·2026
Same journal

Artificial Intelligence in Image-Based Cardiovascular Disease Analysis.

Annual review of biomedical data science·2026
Same journal

Reclaiming Data, Restoring Health: The Indigenous Biomedical Data Science Renaissance.

Annual review of biomedical data science·2026
Same journal

Modeling the Language of Codons with Artificial Intelligence.

Annual review of biomedical data science·2026
Same journal

Exploring Genetic Variations Associated with the Immune Response in Underrepresented Populations.

Annual review of biomedical data science·2026
Same journal

Sex and the Genome: Divergent Genetic Architecture Across the Human Lifespan.

Annual review of biomedical data science·2026
查看所有相关文章

相关实验视频

Updated: May 12, 2026

A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction
00:05

A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction

Published on: August 27, 2019

16.1K

基于网络的方法用于药物目标识别.

Thodoris Koutsandreas1,2, Kalliopi Tsafou3, Heiko Horn1,2

  • 11European Bioinformatics Institute, European Molecular Biology Laboratory, Wellcome Genome Campus, Hinxton, United Kingdom;

Annual review of biomedical data science
|April 16, 2025
PubMed
概括
此摘要是机器生成的。

确定有效的药物点对于药物开发至关重要. 集成多样化的数据的基于网络的方法有望改善目标识别和重新定位,但需要人工智能等先进的方法.

更多相关视频

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

4.9K
Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

4.7K

相关实验视频

Last Updated: May 12, 2026

A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction
00:05

A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction

Published on: August 27, 2019

16.1K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

4.9K
Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

4.7K

科学领域:

  • 生物医学研究的研究.
  • 药理学 药理学是指药理学的学科.
  • 计算生物学是一种计算生物学.

背景情况:

  • 药物标识是药物开发中的一个关键瓶,其成功率很低.
  • 目前的方法往往缺乏对人类复杂疾病的全面了解.

研究的目的:

  • 审查基于网络的药物目标识别和重定位方法的演变和潜力.
  • 确定阻碍临床影响的局限性,并提出解决方案.

主要方法:

  • 对药物发现中的基于网络的方法的审查.
  • 分析用于目标识别的各种数据模式.
  • 讨论新兴技术,如人工智能和知识图.

主要成果:

  • 基于网络的方法为增强药物目标识别和重新定位提供了一个有希望的途径.
  • 目前基于网络的方法的局限性阻碍了临床翻译.

结论:

  • 将多样化的数据与基于网络的策略集成,可以改善药物发现.
  • 建议利用人工智能和知识图来克服现有的局限性并推进临床应用.